I see OCC are also presenting at the HealthInvest event in April. A bit off topic but I'm actually interested to see how OCC Orthocell go with their FDA outcome as they completed FDA 510(k) regulatory study and have submitted their application in Dec CY24. They are expecting FDA clearance Q1 CY25. Will be roughly a 3-4 month turn around by FDA if all goes well for them.
They received regulatory approval in Oct 2024 to allow the company to commence sales. Also have distribution signed to commence sales in Singapore as announced in Nov 2024.
I don't own any shares in OCC but more so interested in the similar pathway EMV will be about to go through and what it will do to share price movements.
This is OCC chart, share price went from $0.40 Sept 2024 to- ~$1.70 recently a 4 times increase.
Higher volume trickled in in September 2024 with probably leak in the positive announcements that was going to occur in the next few months following.
EMV Price at posting:
$1.83 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)